We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIOLABO SAS

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Blood Culture Collection Device Reduces Contamination for Increased Sepsis Testing Accuracy

By LabMedica International staff writers
Posted on 13 Apr 2023
Print article
Image: The Steripath Micro Initial Specimen Diversion Device is fast, easy and effective (Photo courtesy of Magnolia)
Image: The Steripath Micro Initial Specimen Diversion Device is fast, easy and effective (Photo courtesy of Magnolia)

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about 40% of positive results return a false-positive result owing to contamination. Such false-positive results can cause misdiagnosis of sepsis and expose the patient to unnecessary, prolonged, and harmful broad-spectrum antibiotic treatment and extended length of in-patient hospital stay. Preventing false-positive results and sepsis misdiagnosis has to begin with reducing blood culture contaminations. Now, an innovative blood and bodily fluid collection device designed to facilitate significant improvements in the accuracy, consistency, and predictability of critical laboratory tests could reduce sepsis misdiagnosis.

Magnolia Medical Technologies’ (Seattle, WA, USA) Steripath Micro is the only FDA 510(k)-cleared low-diversion volume device platform specifically indicated to reduce blood culture contamination. Developed in collaboration with clinicians from various hospital settings, Steripath Micro optimizes the blood culture collection process by facilitating quick, easy, and effective diversion and test sample collection. Utilizing the same clinically proven Initial Specimen Diversion Device technology as Magnolia's flagship Steripath Initial Specimen Diversion Devices, the Steripath Micro device family combines a small, highly intuitive design for optimal user experience with the speed of traditional blood culture collection methods.

Steripath Micro employs an active blood culture bottle- or syringe-driven diversion method, diverting the initial 0.5 to 1.0 mL of blood into the diversion chamber to prevent potential contaminants from affecting the test blood sample. After the diversion is complete, the clinician simply presses a button to isolate potential contaminants and automatically open a second, sterile blood flow pathway for collecting the test sample. All Steripath Micro needle configurations integrate the BD Vacutainer UltraTouch push button blood collection set. UltraTouch needles feature an ultra-thin-wall cannula, providing a larger inner diameter while maintaining a true-to-gauge size outer cannula diameter (BD RightGauge Technology). This innovative technology allows for increased sample fill volume to be collected into blood culture bottles by enhancing blood flow rates. Additionally, the BD PentaPoint cannula technology integrated into BD Vacutainer UltraTouch wingsets facilitates easier skin penetration.

"We are delighted to launch the expanded family of Steripath Micro configurations as an integral part of our Initial Specimen Diversion Device portfolio. We developed the Steripath Micro platform in close collaboration with our customers to ensure the ability to provide improved blood culture accuracy for all patient populations, including those that are most vulnerable," said Greg Bullington, CEO of Magnolia Medical. "The availability of these configurations will further accelerate our co-selling and co-marketing activities with BD as all Steripath Micro needle configurations come standard with BD's best-in-class UltraTouch needle innovation.

"This new product offering demonstrates our continued commitment to providing hospitals and healthcare systems with the best possible solutions that optimally balance ease of use and clinical performance to support achievement of CLSI and CDC's new 1% goal for blood culture contamination rates," Bullington concluded.

Related Links:
Magnolia Medical Technologies
 

Unit-Dose Twist-Tip BFS
New
Gold Supplier
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
New
Immunoassay Analyzer
DxI 9000
New
Spectrophotometer
UVILINE 9300

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: Medication, sepsis and inadequate blood supply to the kidneys are potential causes of AKI (Photo courtesy of Freepik)

Blood- And Urine-Based Biomarker Tests Could Identify Treatment of Acute Kidney Injury

Hospitalized patients who experience an acute kidney injury (AKI) often face unfavorable outcomes post-discharge, with limited effective treatment options. AKI can stem from various causes, such as sepsis,... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: The first ever diagnostic test accurately predicts patient response to immunotherapy (Photo courtesy of Cofactor)

Immunotherapy Predictive Test Could Spare Cancer Patients from Unnecessary Chemotherapy

In recent years, there has been a significant increase in clinical trials for new cancer drugs. However, only a select group of patients have found success with these newer immunotherapies, which utilize... Read more

Microbiology

view channel
Image: New method reveals bacterial reaction to antibiotics within minutes (Photo courtesy of Freepik)

New Method to Reveal Bacterial Reaction to Antibiotics in Five Minutes Could Help Create Rapid Molecular Test

Severely sick patients suffering from bacterial infections often require immediate treatment to prevent serious health complications, making it vital for physicians to quickly identify the appropriate antibiotic.... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.